Am. J. Respir. Cell Mol. Biol., Vol 13, No. 3, 09 1995, 352-359.
Sulfhydryl-disulfide modulation and the role of disulfide oxidoreductases in regulation of the catalytic activity of nitric oxide synthase in pulmonary artery endothelial cells
JM Patel and ER Block
Department of Medicine, University of Florida, Gainesville, USA.
The role of sulfhydryl groups (SH) and disulfide bonds as well as disulfide
oxidoreductases in regulation of the catalytic activity of the
membrane-bound constitutive isoform of nitric oxide (NO) synthase from
porcine pulmonary artery endothelial cells (PAEC) was examined. Treatment
of intact PAEC or a total membrane preparation isolated from PAEC with the
SH alkylating agent N-ethylmaleimide (NEM) (10 to 50 microM) or with the
intramolecular disulfide-forming agent diamide (20 to 100 microM) resulted
in the reduction of NO synthase activity in a dose-dependent fashion.
Similar loss of enzyme activity was observed when purified NO synthase from
the membrane fraction of PAEC was incubated in the presence of NEM. The
loss of membrane protein SH content from NEM- and diamide-treated
preparations was associated with loss of NO synthase activity. In contrast,
when intact PAEC or isolated total membranes derived from PAEC were treated
with increasing concentrations (1 to 5 mM) of the disulfide-reducing agent
dithiothreitol (DTT), but not oxidized DTT, NO synthase activity was
increased by 20 to 85%. DTT reduction of native disulfides from NEM-
treated preparations or of disulfides formed after diamide treatment of
membranes reversed the inhibition of NO synthase activity. Similarly,
enzymatic reduction by thioredoxin/thioredoxin reductase, but not by
glutaredoxin, reversed the inhibition of membrane fraction and purified NO
synthase isolated from diamide-treated cells. This enzyme-catalyzed
disulfide reduction was > 1,000-fold more efficient than the DTT-
induced reduction.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:

|
 |

|
 |
 
H. Hu, M. Xin, L. L. Belayev, J. Zhang, E. R. Block, and J. M. Patel
Autoinhibitory domain fragment of endothelial NOS enhances pulmonary artery vasorelaxation by the NO-cGMP pathway
Am J Physiol Lung Cell Mol Physiol,
May 1, 2004;
286(5):
L1066 - L1074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Huang, H. Xiao, J. M. Samii, J. A. Vita, and J. F. Keaney Jr.
Contrasting effects of thiol-modulating agents on endothelial NO bioactivity
Am J Physiol Cell Physiol,
August 1, 2001;
281(2):
C719 - C725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kumagai, T. Hayashi, T. Miyauchi, A. Endo, A. Iguchi, M. Kiriya-Sakai, S. Sakai, K. Yuki, M. Kikushima, and N. Shimojo
Phenanthraquinone inhibits eNOS activity and suppresses vasorelaxation
Am J Physiol Regulatory Integrative Comp Physiol,
July 1, 2001;
281(1):
R25 - R30.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Stamler and G. Meissner
Physiology of Nitric Oxide in Skeletal Muscle
Physiol Rev,
January 1, 2001;
81(1):
209 - 237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhang, L. W. Velsor, J. M. Patel, E. M. Postlethwait, and E. R. Block
Nitric oxide-induced reduction of lung cell and whole lung thioredoxin expression is regulated by NF-kappa B
Am J Physiol Lung Cell Mol Physiol,
October 1, 1999;
277(4):
L787 - L793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Patel, Y. D. Li, J. Zhang, C. H. Gelband, M. K. Raizada, and E. R. Block
Increased expression of calreticulin is linked to ANG IV-mediated activation of lung endothelial NOS
Am J Physiol Lung Cell Mol Physiol,
October 1, 1999;
277(4):
L794 - L801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Cremona, T. W. Higenbottam, E. A. Bower, A. M. Wood, and S. Stewart
Hemodynamic Effects of Basal and Stimulated Release of Endogenous Nitric Oxide in Isolated Human Lungs
Circulation,
September 21, 1999;
100(12):
1316 - 1321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. HILL-KAPTURCZAK, M. H. KAPTURCZAK, E. R. BLOCK, J. M. PATEL, T. MALINSKI, K. M. MADSEN, and C. C. TISHER
Angiotensin II-Stimulated Nitric Oxide Release from Porcine Pulmonary Endothelium Is Mediated by Angiotensin IV
J. Am. Soc. Nephrol.,
March 1, 1999;
10(3):
481 - 491.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. C. Das, X.-L. Guo, and C. W. White
Induction of thioredoxin and thioredoxin reductase gene expression in lungs of newborn primates by oxygen
Am J Physiol Lung Cell Mol Physiol,
March 1, 1999;
276(3):
L530 - L539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Patel, J. R. Martens, Y. D. Li, C. H. Gelband, M. K. Raizada, and E. R. Block
Angiotensin IV receptor-mediated activation of lung endothelial NOS is associated with vasorelaxation
Am J Physiol Lung Cell Mol Physiol,
December 1, 1998;
275(6):
L1061 - L1068.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhang, Y. D. Li, J. M. Patel, and E. R. Block
Thioredoxin overexpression prevents NO-induced reduction of NO synthase activity in lung endothelial cells
Am J Physiol Lung Cell Mol Physiol,
August 1, 1998;
275(2):
L288 - L293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C. Das, Y. Lewis-Molock, and C. W. White
Elevation of Manganese Superoxide Dismutase Gene Expression by Thioredoxin
Am. J. Respir. Cell Mol. Biol.,
December 1, 1997;
17(6):
713 - 726.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Wedgwood, D. M. McMullan, J. M. Bekker, J. R. Fineman, and S. M. Black
Role for Endothelin-1-Induced Superoxide and Peroxynitrite Production in Rebound Pulmonary Hypertension Associated With Inhaled Nitric Oxide Therapy
Circ. Res.,
August 17, 2001;
89(4):
357 - 364.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 American Thoracic Society.
|
|
|